PTGS1 and cancer: We have discovered that when platelets and cancer cells are cultured together, inhibiting platelet COX-1 using aspirin or blocking the P2Y12 receptor with antagonists can prevent the platelet-induced epithelial-mesenchymal transition (EMT) phenomenon and migration of cancer cells in vitro (Guillem-Llobat et al., 2016).